5887 Medicine & Nursing courses delivered Online

Specializing in Corrective Exercise with NASM can stretch your earning potential along with your clients’ abilities to reduce the risk of injury—helping them move, feel and live better. By becoming a Corrective Exercise Specialist, you’ll take your fitness career and ability to help your clients to new levels. You’ll learn how to assess clients in a whole new way. It will help you better identify their movement compensations, where they are weak or strong, and hone your ability to use that knowledge to design effective and efficient programs. You’ll take your ability to assess clients from generalized to specific, breaking assessments down into smaller, more in-depth pieces so you can identify different parts of the body in need of attention.

A 505(b)(2) New Drug Application (NDA) is a submission to the Food and Drug Administration (FDA) for approval to market a drug in the USA. It differs from a ‘stand-alone’ NDA in that some of the data on which the applicant relies to demonstrate safety and efficacy have been obtained from publicly available sources rather than from the applicant’s own studies. The applicant typically proposes to market a drug that is based on an approved reference product but modified in its formulation or uses. A 505(b)(2) NDA also differs from an Abbreviated New Drug Application (ANDA) for approval of a generic drug in that the applicant’s product need not be a duplicate of the reference listed drug. The 505(b)(2) pathway may be said to lie part-way between the ‘stand-alone’ NDA and generics pathways, offering a unique combination of advantages to developers. It facilitates the modification of drugs to address unmet medical needs. The 505(b)(2) application pathway accounts for about half of all new drug approvals in the USA.

3 QLS Endorsed Diploma | QLS Hard Copy Certificate Included | 10 CPD Courses | Lifetime Access | 24/7 Tutor Support